Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

SCHIZOPHRENIA

Apply to participate in a study of an investigational medication for schizophrenia

BUNION

Apply to participate in a study of an investigational pain medication following a bunion removal

BIPOLAR DISORDER

Apply to participate in a study of an investigational medication for Bipolar Disorder

DEPRESSION

Take a self assessment to see if you qualify for a no cost mental health assessment with our medical team